The experiments were based on the reports that HGF is a potent activator of membrane type-1 matrix metalloproteinase (MT1-MMP) in breast cancer cells [39], in a PKCζ-dependent manner [40], is a proteolytic enzyme known to be involved in degrading extracellular matrix and assist in cancer invasion and progression. This evidence concerns the gene HGF and breast carcinoma.